ALLR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Allarity Therapeutics Inc (ALLR) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The absence of positive financial performance, lack of significant trading trends, and no recent news or catalysts make this stock less appealing for immediate investment. A 'hold' action is recommended until more favorable data or signals emerge.
The MACD is positive and expanding (0.0203), indicating slight bullish momentum. RSI is neutral at 60.252, and moving averages are converging, suggesting no strong trend. The stock is trading near its resistance level (R1: 1.051), which might limit immediate upside potential.
NULL identified. No recent news, no significant hedge fund or insider activity, and no congress trading data.
The company's financial performance in Q3 2025 is weak, with a significant drop in net income (-76.91% YoY) and EPS (-97.54% YoY). No recent news or events to drive positive sentiment.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -$2,806,000 (-76.91% YoY), and EPS fell to -0.19 (-97.54% YoY). Gross margin also remained at 0, indicating no profitability.
No data available for analyst ratings or price target changes.
